marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-13-2023
Eloxx Pharmaceuticals Financial Statements 2011-2024 | ELOX
Annual Financial Statements Eloxx Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
6.15 M | 1.24 M | 138 M | 149 M | 374 M | 6.5 M | 3.66 M | 10.7 M | 11.4 M | 4.1 M | 22.3 M | 18 M |
Shares |
2.17 M | 1.75 M | 40.1 M | 38.1 M | 32.4 M | 1.16 M | 1.02 M | 721 K | 274 K | 68.3 K | 42.9 K | 34.7 K |
Historical Prices |
2.84 | 0.71 | 3.98 | 7.36 | 12 | 8 | 2.8 | 8 | 16.4 | 120 | 320 | 520 |
Net Income |
-36.1 M | -66.7 M | -34.6 M | -50.9 M | -47.2 M | -5.8 M | -8.27 M | -18.1 M | -9.23 M | -6.12 M | -5.07 M | -7.27 M |
Revenue |
- | - | - | - | - | - | 75 K | 75 K | 100 K | - | 200 K | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | 200 K | - |
Operating Income |
-34.4 M | -66 M | -33.5 M | -50.6 M | -47.6 M | -20.4 M | -9.84 M | -6.28 M | -9.15 M | -4.65 M | -5.41 M | -7.92 M |
Interest Expense |
-1.65 M | -709 K | -1.12 M | -319 K | 502 K | -824 K | -7 K | - | - | - | - | -116 K |
EBITDA |
-34.3 M | -65.9 M | -33.4 M | -50 M | -46.8 M | -2.1 M | -3.62 M | -7.66 M | -6.59 M | -4.29 M | -4.83 M | -6.19 M |
Operating Expenses |
34.4 M | 66 M | 33.5 M | 50.6 M | 47 M | 2.14 M | 3.79 M | 7.74 M | 7.02 M | 4.59 M | 5.29 M | 6.33 M |
General and Administrative Expenses |
10.7 M | 20.4 M | 14.8 M | 24.7 M | 26.5 M | 1.46 M | 1.41 M | 2.74 M | 2.62 M | 2.1 M | - | - |
All numbers in USD currency
Quarterly Income Statement Eloxx Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
2.75 M | 2.21 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | 86.6 M | 86.2 M | 66.4 M | 40.2 M | 40.2 M | 40.1 M | 40.1 M | 40.1 M | 40 M | 39.9 M | 36.3 M | 35.9 M | 35.9 M | 35 M | 31.8 M | 27.5 M | 27.5 M | 4.21 M | 4.21 M | 41.5 M | 20.7 M | 20.5 M | 20.6 M | 20.4 M | 20.4 M | 20 M | 20.4 M | 20 M | 13.9 M | 13.8 M | 13.9 M | 13.8 M | 3.44 M | 2.31 M | 3.44 M | 2.31 M | 1.17 M | 1.07 M | 117 M | 107 M | 80.8 M | 79.3 M | 77.8 M | 77.8 M |
Net Income |
-3.59 M | -4.34 M | -6.23 M | - | -7.51 M | -10.6 M | -11.6 M | - | -9.88 M | -36.1 M | -8.69 M | - | -6.62 M | -7.89 M | -13.9 M | - | -12.9 M | -14.4 M | -11.9 M | - | -11.2 M | -13.4 M | -8.59 M | -10.6 M | -4.04 M | -3.88 M | -1.27 M | -790 K | -934 K | -1.72 M | -934 K | -3.86 M | -181 K | -3.86 M | -181 K | -10.7 M | -5.18 M | -10.7 M | -5.18 M | -1.62 M | -1.78 M | -1.62 M | -1.78 M | -1.27 M | -2.09 M | -1.27 M | -2.09 M | -1.53 M | -1.04 M | -1.53 M | -1.04 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.79 M | 200 K | - | 200 K | 1.59 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-3.64 M | -4.14 M | -5.48 M | - | -7.14 M | -10.3 M | -11 M | - | -10.2 M | -35.7 M | -8.41 M | - | -6.3 M | -7.59 M | -13.8 M | - | -12.8 M | -14.3 M | -12 M | - | -11.4 M | -13.5 M | -8.55 M | - | -4 M | -3.18 M | -627 K | -1.51 M | -2.21 M | -3.72 M | -4.89 M | -3.76 M | -1.15 M | -3.76 M | -1.15 M | -10.7 M | -5.19 M | -10.7 M | -5.19 M | -1.59 M | -1.75 M | -1.59 M | -1.75 M | -1.3 M | -1.25 M | -1.3 M | -1.25 M | -1.46 M | -1.28 M | -1.46 M | -1.28 M |
Interest Expense |
45 K | -201 K | -747 K | - | -366 K | -322 K | -667 K | - | 360 K | -329 K | -280 K | - | -321 K | -301 K | -179 K | - | -96 K | -138 K | 60 K | - | 199 K | 137 K | -43 K | - | -40 K | -699 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 205 K | - | -116 K | 205 K | 205 K |
EBITDA |
- | - | -5.47 M | - | -7.12 M | -10.3 M | -10.9 M | - | -10.2 M | -35.7 M | -8.4 M | - | -6.28 M | -7.57 M | -13.7 M | - | -12.8 M | -14.3 M | -11.9 M | - | -11.3 M | -13.5 M | -8.53 M | - | -3.99 M | -3.17 M | -621 K | -1.51 M | -2.2 M | -3.69 M | -4.88 M | -3.76 M | -1.12 M | -3.7 M | -1.12 M | -10.7 M | -5.13 M | -10.6 M | -5.13 M | -1.51 M | -1.68 M | -1.44 M | -1.68 M | -1.23 M | -1.18 M | -1.17 M | -1.18 M | -1.46 M | -1.22 M | -1.34 M | -1.22 M |
Operating Expenses |
3.64 M | 4.14 M | 5.48 M | - | 7.14 M | 10.3 M | 11 M | - | 10.2 M | 35.7 M | 8.41 M | - | 6.3 M | 7.59 M | 13.8 M | - | 12.8 M | 14.3 M | 12 M | - | 11.4 M | 13.5 M | 8.55 M | - | 4 M | 3.18 M | 2.63 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.39 M | 1.8 M | 2 M | - | 2.26 M | 2.64 M | 3.05 M | - | 5.04 M | 7.36 M | 4.34 M | - | 2.85 M | 3.85 M | 5.01 M | - | 5.98 M | 6.97 M | 5.96 M | - | 5.94 M | 9.56 M | 3.39 M | 2.2 M | 720 K | 584 K | 492 K | 300 K | 480 K | 780 K | 332 K | 401 K | 587 K | 401 K | 587 K | 1.25 M | 775 K | 1.25 M | 775 K | 858 K | 857 K | 942 K | 940 K | 709 K | 733 K | 709 K | 733 K | 905 K | 646 K | 905 K | 646 K |
All numbers in USD currency